$1,500,000 FUNDED! 🎉

About the Company

A leading Canadian medtech innovator is revolutionizing the global MRI market with its patented communication technology, designed to enhance patient experience and streamline workflow in high-noise imaging environments. By integrating biosignal monitoring with real-time communication, this company is setting a new standard for MRI procedures worldwide.

Backed by strategic partnerships and a strong clinical pipeline, they are nearing commercialization with global demand already secured. However, with a monthly burn rate of $300K and a $10M equity injection pending from investors, the company faced a critical cash crunch that threatened to stall their momentum.

Funding Success

We arranged a $1.5M SR&ED-backed bridge facility to provide essential working capital during this pivotal phase. The funding is covering near-term operating costs and final R&D expenses, ensuring they maintain momentum through the last 10% of product development and fulfill millions in pending purchase orders from industry leaders.

By preserving runway and stabilizing operations, this bridge financing keeps commercialization on track and supports the company’s mission to transform MRI efficiency and patient care on a global scale.

Why it Matters

✅ Final development stages 90% complete

✅ Purchase orders secured—awaiting delivery

✅ Unlocking a $7B+ total addressable market

✅ Backing patented, game-changing MRI technology